BRY805

· BioRay Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BRY805, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BRY805 in Participants With Advanced Solid Tumors [Phase 1]